Quarterly ResultMay 20, 2026, 06:08 AM
CorVel FY26 Revenue $959M (+7%), EPS $2.14 (+17%)
AI Summary
CorVel Corporation announced strong financial results for the fiscal year and fourth quarter ended March 31, 2026. Fiscal year revenues increased 7% to $959 million, with diluted earnings per share rising 17% to $2.14. For the fourth quarter, revenues grew 7% to $249 million, and diluted EPS increased 20% to $0.61. The company also reported $233 million in cash, repurchased $20.1 million of common stock, and highlighted growth in its CERIS health division and advancements in P&C services through technology and AI.
Key Highlights
- Fiscal year 2026 revenues increased 7% to $959 million from $896 million in FY2025.
- Fiscal year 2026 diluted EPS rose 17% to $2.14 from $1.83 in FY2025.
- Fourth quarter 2026 revenues increased 7% to $249 million from $232 million in Q4 2025.
- Fourth quarter 2026 diluted EPS grew 20% to $0.61 from $0.51 in Q4 2025.
- Gross profit for Q4 2026 increased 9% to $63.0 million, achieving a 25% gross margin.
- Exited the quarter with $233 million in cash, cash equivalents, and no borrowings.
- Repurchased $20.1 million of common stock during the fourth quarter.
- CERIS health division is benefiting from strong demand for its integrated prepay and post-pay platform.
- P&C services are advancing technology-enabled, clinically integrated models through CorVel ConnectedTM.
Price Impact
More from CRVL